Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Nebor, Danitza ^a,b   Bowers, Andre ^c   Connes, Philippe ^a,b,d,e,f,g   Hardy Dessources, Marie Dominique ^a,b,d,f   Knight Madden, Jennifer ^f,h   Cumming, Vanessa ^h   Reid, Marvin ^f,h   Romana, Marc ^a,b,d,f  

^a INSERM   (France)

^b UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

^d Laboratory of Excellence GR Ex   (France)

^e University of the French West Indies   (France)

^f CAribbean Network of REsearchers on Sickle Cell Disease and Thalassemia   (France)

^g INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^h UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE MICROPARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; SICKLE CELL ANEMIA; ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD; CHEMISTRY; COMPLICATION; FLOW CYTOMETRY; METABOLISM; MIDDLE AGED; PAIN; PARTICLE SIZE; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; THROMBOCYTE;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PAIN; PARTICLE SIZE; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 84899806135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087243     Document Type: Article

References (25)

1. Stuart MJ, Nagel RL (2004) Sickle-cell disease. Lancet 364: 1343-1360. (Pubitemid 39335827)
2. Sparkenbaugh E, Pawlinski R (2013) Interplay between coagulation and vascular inflammation in sickle cell disease. Br J Haematol 162: 3-14.
3. Wood KC, Hsu LL, Gladwin MT (2008) Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med 44: 1506-1528.
4. Lamarre Y, Hardy-Dessources MD, Romana M, Lalanne-Mistrih ML, Waltz X, et al. (In press) Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease. Clin Hemorheol Microcirc.
5. Lamarre Y, Romana M, Lemonne N, Hardy-Dessources MD, Tarer V, et al. (2013) Alpha thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties. Clin Hemorheol Microcirc.
6. Lamarre Y, Romana M, Waltz X, Lalanne-Mistrih ML, Tressieres B, et al. (2012) Hemorheological risk factors of acute chest syndrome and painful vasoocclusive crisis in children with sickle cell disease. Haematologica 97: 1641-1647.
7. Nebor D, Bowers A, Hardy-Dessources MD, Knight-Madden J, Romana M, et al. (2011) Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica 96: 1589-1594.
8. Steinberg MH (2005) Predicting clinical severity in sickle cell anaemia. Br J Haematol 129: 465-481.
9. Owens AP 3rd, Mackman N (2011) Microparticles in hemostasis and thrombosis. Circ Res 108: 1284-1297.
10. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, et al. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102: 2678-2683. (Pubitemid 37193612)
11. van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, et al. (2009) Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 94: 1513-1519.
12. van Tits LJ, van Heerde WL, Landburg PP, Boderie MJ, Muskiet FA, et al. (2009) Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis. Biochem Biophys Res Commun 390: 161-164.
13. Nebor D, Romana M, Santiago R, Vachiery N, Picot J, et al. (2013) Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica 98: 862-867.
14. Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khaterchi A, et al. (2012) The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb Haemost 107: 1044-1052.
15. Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13: 269-288.
16. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, et al. (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 142: 126-135. (Pubitemid 351783151)
17. Rank A, Nieuwland R, Crispin A, Grutzner S, Iberer M, et al. (2011) Clearance of platelet microparticles in vivo. Platelets 22: 111-116.
18. Willekens FL, Werre JM, Kruijt JK, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, et al. (2005) Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105: 2141-2145. (Pubitemid 40731805)
19. Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115: 721-728. (Pubitemid 38032666)
20. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, et al. (1998) Platelet activation in patients with sickle cell disease. Br J Haematol 100: 741-749. (Pubitemid 28126109)
21. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106: 1604-1611. (Pubitemid 41208572)
22. Lentz BR (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 42: 423-438.
23. Camus SM, Gausseres B, Bonnin P, Loufrani L, Grimaud L, et al. (2012) Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 120: 5050-5058.
24. Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, et al. (2013) The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 98: 464-472.
25. Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21: 37-47. (Pubitemid 46110926)